Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J David Leander

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|October 3, 2003
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze taskMary C Wolff, J David Leander
Psychopharmacology|April 24, 2003
Comparison of the effects of antipsychotics on a delayed radial maze task in the ratMary C Wolff, J David Leander
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeonMary C Wolff, J David Leander
Expert Opinion on Investigational Drugs|November 21, 2013
GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonistsJoseph R Moskal, Ronald Burch, Jeffrey S Burgdorf, et al.
Frontiers in Psychiatry|June 8, 2017
Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive DisorderMichelle M Rodriguez, Carl Overshiner, J David Leander, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effectsJeffrey Burgdorf, Xiao-lei Zhang, Katherine L Nicholson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|October 3, 2003
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze taskMary C Wolff, J David Leander
Psychopharmacology|April 24, 2003
Comparison of the effects of antipsychotics on a delayed radial maze task in the ratMary C Wolff, J David Leander
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeonMary C Wolff, J David Leander
Expert Opinion on Investigational Drugs|November 21, 2013
GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonistsJoseph R Moskal, Ronald Burch, Jeffrey S Burgdorf, et al.
Frontiers in Psychiatry|June 8, 2017
Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive DisorderMichelle M Rodriguez, Carl Overshiner, J David Leander, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effectsJeffrey Burgdorf, Xiao-lei Zhang, Katherine L Nicholson, et al.
Pageof 1